MedPath
FDA Approval

SILDENAFIL CITRATE

FDA-approved pharmaceutical product with comprehensive regulatory information, manufacturing details, and complete labeling documentation.

FDA Approval Summary

Company
Effective Date
April 25, 2023
Labeling Type
HUMAN PRESCRIPTION DRUG LABEL
Sildenafil(50 mg in 1 1)

Registrants1

Companies and organizations registered with the FDA for this drug approval, including their contact information and regulatory details.

PD-Rx Pharmaceuticals, Inc.

156893695

Manufacturing Establishments1

FDA-registered manufacturing facilities and establishments involved in the production, packaging, or distribution of this drug product.

PD-Rx Pharmaceuticals, Inc.

PD-Rx Pharmaceuticals, Inc.

PD-Rx Pharmaceuticals, Inc.

156893695

Products1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

SILDENAFIL CITRATE

Product Details

NDC Product Code
43063-941
Application Number
ANDA091448
Marketing Category
ANDA (C73584)
Route of Administration
ORAL
Effective Date
April 25, 2023
CROSCARMELLOSE SODIUMInactive
Code: M28OL1HH48Class: IACT
CALCIUM PHOSPHATE, DIBASIC, ANHYDROUSInactive
Code: L11K75P92JClass: IACT
HYPROMELLOSE 2910 (6 MPA.S)Inactive
Code: 0WZ8WG20P6Class: IACT
SODIUM STEARYL FUMARATEInactive
Code: 7CV7WJK4UIClass: IACT
CELLULOSE, MICROCRYSTALLINEInactive
Code: OP1R32D61UClass: IACT
FD&C BLUE NO. 2Inactive
Code: L06K8R7DQKClass: IACT
Code: BW9B0ZE037Class: ACTIMQuantity: 50 mg in 1 1
TITANIUM DIOXIDEInactive
Code: 15FIX9V2JPClass: IACT
TRIACETINInactive
Code: XHX3C3X673Class: IACT
© Copyright 2025. All Rights Reserved by MedPath